Format

Send to

Choose Destination
See comment in PubMed Commons below
Trends Parasitol. 2004 Feb;20(2):92-7.

Schistosomiasis control: keep taking the tablets.

Author information

1
Division of Infection and Immunity, Institute of Biomedical and Life Sciences, Joseph Black Building (B4-09d), University of Glasgow, G12 8QQ, UK. p.hagan@bio.gla.ac.uk

Abstract

Despite the limited reports of praziquantel resistance, the relative success of chemotherapy-based control programmes for schistosomiasis has prompted overdue efforts to expand the use of cheap, generic, praziquantel in sub-Saharan Africa. The likely impact of such programmes on the development and spread of praziquantel resistance is uncertain, but this possibility reinforces the need for monitoring the spectrum of praziquantel sensitivity of schistosome populations and for an improved knowledge of the precise targets for the action of the drug. The search for alternatives to praziquantel and other tools for control of schistosomiasis must continue.

PMID:
14747023
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Support Center